TABLE 1.
Clinical Data | Basal Cell Carcinoma | |
---|---|---|
Age | Female | Male |
< 20 years | - | - |
21- 40 years | 3 (8.3%) | 3 (4.8%) |
41- 60 years | 21 (58.3%) | 12 (19.4%) |
> 60 years | 12 (33.3%) | 47 (75.8%) |
Histological Type | ||
Superficial | 9 (25%) | 10 (16.1%) |
Nodular | 13(36.1%) | 24 (38.7%) |
Morpheaform | 6 (16.7%) | 9 (14.5%) |
Pigmented | - | 3 (4.8%) |
Mixed | 8 (22.2%) | 16 (25.8%) |
Diameter | ||
< 5 mm | 18 (50.0%) | 15 (24.2%) |
5- 10 mm | 12 (33.3%) | 44 (71.0%) |
10- 15 mm | 3 (8.3%) | - |
15- 20 mm | 3 (8.3%) | 3 (4.8%) |
Location | ||
Trunk | 12 (33.3%) | 28 (45.2%) |
Head and Neck | 18 (50.0%) | 25 (40.3%) |
Lower extremity | 6 (16.7%) | 6 (9.7%) |
Upper extremity | - | 3 (4.8%) |
Skin Type of Fitzpatrick | ||
1 | 21 (58.3%) | 28 (45.2%) |
2 | 12 (33.3%) | 25 (40.3%) |
3 | 3 (8.3%) | 9 (14.5%) |